Methicillin-resistant Staphylococcus aureus infection in the obstetric setting.
Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly prevalent pathogen, both in the community and in hospitalized patients. The virulence of MRSA, coupled with its resistance to many frequently prescribed antibiotics, requires increased vigilance in the assessment and diagnosis of skin and soft tissue infections. This article reviews the epidemiology of MRSA and focuses on treatment of MRSA when it is diagnosed during pregnancy.
Kriebs
Jan M
JM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001942:Breast Feeding; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D017053:Infection Control / Q000379:methods; D008413:Mastitis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D016106:Methicillin Resistance; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects / Q000472:pathogenicity
D000900:Anti-Bacterial Agents